We support research at the global forefront of science
Tissue engineering, regenerative & personalized medicine, pharma, medical device industry, cosmetics, drug discovery, and many other applications are using our technology to their advantage.
Some scientific projects using regenHU 3D bioprinters :
Scientific Publications Partners Achievements
PARTNERS ACHIEVEMENTS
08.05.2019
Walliser Bote Zeitung
Die Curio Biotech SA in Visp bietet eine Alternative für Kosmetik- und Medikamententests
"Die Curio Biotech SA in Visp testet Kosmetikprodukte oder Medikamente im Labor an menschlichen Zellkulturen. Mit solchen Prozedere lassen sich viele Tierversuche vermeiden. Ein weiterer Vorteil: Es kann für Menschen gar aussagekräftigere Resultate liefern."
copyright: Walliser Bote / Fotos WB/ANDREA SOLTERMANN
Steriler Arbeitsplatz. Dr. Chennakesava Cuddapah achtet auf eine sterile Arbeitsumgebung. Die In-vitro-Modelle und Zellkulturen dürfen nicht verunreinigt werden.
source : Walliser Bote Zeitung
15.04.2019
Tel-Aviv University
3D Printing of Personalized Thick and Perfusable Cardiac Patches and Hearts
Once again, the flexibility of our technologies is showcased. 3DDiscovery™ Evolution was adapted to FRESH 3D Bioprinting to build vascularized and perfusable cardiac patches.
ABSTRACT : "Generation of thick vascularized tissues that fully match the patient still remains an unmet challenge in cardiac tissue engineering. Here, a simple approach to 3D‐print thick, vascularized, and perfusable cardiac patches that completely match the immunological, cellular, biochemical, and anatomical properties of the patient is reported. To this end, a biopsy of an omental tissue is taken from patients....
13.03.2019
AO Research Institute
A Stimuli-Responsive Nanocomposite for 3D Anisotropic Cell-Guidance and Magnetic Soft Robotics
"A novel method is presented to biofabricate anisotropic nanocomposite hydrogels through a mild and biocompatible process driven by multiple external stimuli: magnetic field, temperature, and light. The functionality of this stimuliresponsive hydrogel is studied creating i) 3D cell-instructive platforms for in vitro morphogenesis, and ii) a 3D printable magnetoresponsive ink for fabricating small-scale bioinspired soft robots"
source : Advandced Science News
18.02.2019
University of Glasgow
Bioprinting with Biogelx-Ink
Álvaro Sánchez Rubio, a Ph.D. researcher at the University of Glasgow, is printing with Biogelx-Ink-S.
Source: Biogelx Limited
05.02.2019
UMC Utrecht
Replicating the architecture of cartilage and bone
"This project has received funding from the European Research Council (ERC) under the: European Union’s Horizon 2020 research and innovation programme (grant agreement No [647426])"
sources: UMC Utrecht
14.01.2019
IMPACT zhaw
Pionier für menschliches Gewebe aus dem Drucker
"Markus Rimann hat das Fachgebiet des Bioprinting an der ZHAW aufgebaut. Das Ziel: menschliches Gewebe für eine effiziente Medikamentenentwicklung."
"Markus Rimann am 3D-Bioprinter, der sich hinter der Scheibe in einer sterilen Umgebung befindet. Mit der auf dem Bildschirm geöffneten Software, lässt sich der Drucker steuern."
Sources
www.zhaw.ch
IMPACT-zhaw-Dez2018
05.12.2018
BioArk bridges industries with innovation
3D cell culture at Curio Biotech mimicks in vivo conditions.
Curio Biotech is a start-up CRO company providing services to clients ln the lite sciences sector of the pharma, cosmetlc, nutraceutlcal and diagnostic industries.
Curio Biotech constantly improves existing 30 cell culture systems and further develops novel in vitro models.
These novel 30 cell cultures can be used not only for in vitro drug discovery, screening of compounds and pre-clinlcal investigation, but can also be translated for various clinical applications.
03.09.2018
Science Daily
A novel microplate 3D bioprinting platform for the engineering of muscle and tendon tissues
In our ageing society, there is a huge medical need for therapies against degenerative muscle and tendon diseases. This study by researchers from ZHAW and Novartis Institutes for Biomedical Research describes a novel drug screening platform with automated production of 3D musculoskeletal-tendon-like tissues, representing a promising tool to address musculoskeletal diseases. Cells and bioink were printed using the 3DDiscovery™ bioprinter, in dumbbell lines designed by regenHU’s integrated BioCAD™ program.
